Accordingly, we suggest that the CRD of galectin-3 monomers interact with HIV-1 gp120 or CD4 molecules, triggering galectin-3 oligomers formation to further enhance their binding capabilities to CD4 or gp120, respectively, thus facilitating HIV-1 CRF07_BC infection. This evidence concerns the gene LGALS3 and breast cancer.